Synthetics Biologics Stock Predictions

Healthcare > Biotechnology

Buy SYN

*Your capital is at risk

$0.91

+0.0050 (+0.556%)

At Close: Jan 27, 2023

Currently predicting for Mon, 8 Jun 2026

SYN Prediction Chart

SYN Predictions History

Latest community submissions for SYN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
rleonid Amateur	Jul 27, 2021	$0.490 -3.16%	$0.506	X	96.84%	1
rleonid Amateur	Jul 26, 2021	$0.527 +2.89%	$0.512	X	97.11%	1
JS Pro	Jun 1, 2021	$0.528 +2.80%	$0.514	X	97.20%	0
contact230215	Jun 1, 2021	$0.613 +19.35%	$0.514	X	80.65%	0
JS Pro	May 24, 2021	$0.549 +6.81%	$0.514	X	93.19%	0
ullh82w8 Amateur	May 24, 2021	$0.550 +7.00%	$0.514	X	93.00%	1
JS Pro	May 18, 2021	$0.491 -4.29%	$0.513	X	95.71%	0
motoxfresty.238886	May 18, 2021	Bearish	$0.513	X	—	0
JS Pro	May 13, 2021	$0.475 +3.13%	$0.461	X	96.87%	1
JS Pro	May 4, 2021	$0.514 -0.50%	$0.517	X	99.50%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SYN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SYNTHETICS BIOLOGICS INC

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
FIZZ $34.11	7.04%	May 01
W WCLD $27.34	17.78%	Apr 29
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by